Clene
CLNN
Clene (CLNN) news
Recent news
ImportantClene plunges 32% premarket after FDA said that initial findings on biomarker NFL reduction from Phase 2 programs were insufficient
Clene plunges 32% premarket after FDA said that initial findings on biomarker NFL reduction from Phase 2 programs were insufficient Clene Inc. saw its stock plunge 32% premarket after the Food and Drug Administration (FDA) stated that the initial findings on the biomarker Neurofilament Light Chain…
AInvest Wire · Dec 21, 2023ImportantClene jumps 7% premarket after announcing CNM-au8 improved survival with a 49% decreased risk of death
AInvest Wire · Sep 25, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.